Mindfulness clinical trials at UCSD
3 in progress, 2 open to eligible people
Mindfulness Engaged Neurostimulation for Depression
open to eligible people ages 18-65
Repetitive Transcranial Magnetic stimulation (rTMS) is an FDA-approved therapy for treatment resistant depression (TRD) that involves brief magnetic stimulation pulses on the dorsolateral prefrontal cortex (DLPFC) brain region. But studies of rTMS alone show remission rates of ~30%. Additionally, rTMS has not been shown to improve cognitive functioning that may be an independent factor predicting treatment success. This study will develop a novel multimodal treatment, which combines intermittent theta burst stimulation (iTBS) - a type of rTMS with digital mindfulness training to engage brain plasticity, enhance cognition and alleviate depression symptoms in individuals with TRD.
La Jolla, California
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
open to eligible people ages 18 years and up
The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care as interventions to reduce chronic pain, improve quality of life, and reduce opioid-related harms among chronic pain patients on long-term opioid therapy.
La Jolla, California and other locations
Interoceptive Training Enhanced Mindfulness
Sorry, not yet accepting patients
This pilot randomized controlled trial will compare a novel mindfulness training to interoceptive exposure to establish feasibility and acceptability as an intervention for anxiety sensitivity.
San Diego, California
Our lead scientists for Mindfulness research studies include Jyoti Mishra, PhD.
Last updated: